Redhill Biopharma
RDHL
C$2.04
Share price
-9.20%
Change (1 day)
-85.03%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Net assets
Net assets on the balance sheet as of December 2024 : -C$6.45 Million
According to Redhill Biopharma's latest financial reports the company has -C$6.45 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Redhill Biopharma - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $C$2.74 M | -104.18% |
| 2022-12-31 | $-C$65.68 Million | -680.66% |
| 2021-12-31 | $C$11.31 M | -36.02% |
| 2020-12-31 | $C$17.67 M | -77.44% |
| 2019-12-31 | $C$78.36 M | 12.39% |
| 2018-12-31 | $C$69.72 M | 23.06% |
| 2017-12-31 | $C$56.65 M | -32.76% |
| 2016-12-31 | $C$84.26 M | 1.11% |
| 2015-12-31 | $C$83.33 M | 187.13% |
| 2014-12-31 | $C$29.02 M | 128.65% |
| 2013-12-31 | $C$12.69 M | -32.88% |
| 2012-12-31 | $C$18.91 M | -1.04% |
| 2011-12-31 | $C$19.11 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | C$110.85 B | -1,719,339.80% | 🇫🇷 France |
 Merck MRK | C$66.64 B | -1,033,625.52% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$24.29 B | -376,828.59% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | C$2.44 B | -38,090.39% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | C$8.63 B | -133,967.18% | 🇮🇱 Israel |